Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?

Clin Exp Rheumatol. 2021 Nov 3. Online ahead of print.NO ABSTRACTPMID:34796848
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Authors: Source Type: research